Pulse
NIFTY 5024,980.40+0.35%
SENSEX81,720.10+0.28%
NIFTY SHARIAH 254,850.15+0.42%
GOLD 24K (10g)₹75,420+0.38%
SILVER (1kg)₹88,400-0.12%
ACTIVE IPOS8 Open+38% GMP
TCS₹4,124.50+1.18%
INFY₹1,892.40+1.22%
USD/INR₹83.92-0.04%
NIFTY 5024,980.40+0.35%
SENSEX81,720.10+0.28%
NIFTY SHARIAH 254,850.15+0.42%
GOLD 24K (10g)₹75,420+0.38%
SILVER (1kg)₹88,400-0.12%
ACTIVE IPOS8 Open+38% GMP
TCS₹4,124.50+1.18%
INFY₹1,892.40+1.22%
USD/INR₹83.92-0.04%
Sika Interplant Systems Limited

Sika Interplant Systems Limited

NSE: SIKA
Aerospace & DefenseElectronic TechnologySMALL CAPMCap ₹2.16k Cr
₹1,020.40₹-8.30 (-0.81%)

Market Closed • NSE

Market cap₹2.16k Cr
Enterprise value₹2.15k Cr
P/E TTM62.41
P/B13.21
EPS TTM₹16.35
ROCE34.60%
ROE0.23%
ROA0.13%
D/E2.10
Dividend yield0.00%
Face value₹2.00
52W high₹1,111.00
52W low₹962.50
Price chart(1Y)
1Y Return:+12.73% (+₹115.20)
H: ₹1,359.4L: ₹871.35
1W-0.22%
1M-0.43%
3M-8.53%
Today at a glance

Day range

₹1,010.70₹1,041.30

52 week range

₹962.50₹1,111.00
Volume14.6K0.24x 20D avg
Free float50.00%-75.90% volume

Sika Interplant Systems Limited closed at INR1020.40 (-0.81%) on volume 0.24x its 20-day average, trading 8.15% below its 52-week high.

Technical analysis
RSI (14)46.8Neutral (30–70)
MACDBEARISHBearish (Below signal)
ATR (14)₹45.37High
SMA 20₹1,042.64BEARISH
SMA 50₹1,048.51BEARISH
SMA 100₹1,031.92BEARISH
SMA 200—N/A
CPR bottom₹1,043.20
Pivot₹1,038.37
CPR top₹1,033.53
What changed recently?

2026-Q2

Q2 FY2026 Financial Results

PAT moved +7.3% QoQ

2026-08-05

DIVIDEND Announced

Dividend - Rs 3.50 Per Share

Shariah audit
Methodology: AAOIFI Shariah Standard No. 21
PASS4/4 criteria
Shariah Compliant
CriteriaNumeratorDenominatorValueThresholdStatus
Interest-bearing debt ratio–₹2.16k Cr0.00%≤ 33%PASS
Non-halal income ratio–₹211.0 Cr0.00%≤ 5%PASS
Illiquid assets ratio–₹175.0 Cr—≥ 20%PASS
Receivables ratio–₹175.0 Cr—≤ 49%PASS
Valuation & sector context
MetricCompanySector
P/E62.4162.40
Forward P/E——
P/B13.2113.20
EV/EBITDA47.9018.00
PEG—1.50
Earnings yield1.601.60
Growth & profitability
RevenuePAT
FY21PAT margin 15.00%
FY22PAT margin 17.30%
FY23PAT margin 15.00%
FY24PAT margin 17.90%
FY25PAT margin 16.90%
FY26PAT margin 17.10%

Revenue and PAT bars use independent scales to make their year-on-year direction readable.

Revenue CAGR 3Y+52.10%
Revenue CAGR 5Y+21.40%
PAT CAGR 3Y+58.70%
PAT CAGR 5Y+24.60%
Operating margin18.72%
Net margin18.54%
Financial health & cash flow
Net debt–Healthy
Interest coverage45.00xEBIT / interest
CFO / PAT0.94x3Y average
Net debt / EBITDA0.00xLeverage
Operating cash flow₹47.0 Cr
Capital expenditure–
Free cash flow₹47.0 Cr
Financial statements

Complete reported financial history · Values use the company's reporting currency

Hover over the chart for exact reported values. Percentage lines use the right-hand axis.

Fundamental scorecard
Overall50/100
Valuation35/100
Profitability80/100
Financial health35/100

A 0–100 quantitative summary of reported fundamentals. Use the underlying financials and risks for context; the score is not a buy or sell recommendation.

Strengths, risks & investment thesis

Strengths

Strong Capital Efficiency: ROCE stands at 34.6%

Risks

Elevated Leverage Burden: Debt-to-Equity stands at 2.10x

Stretched Valuation: Trading at a high P/E multiple of 62.4x

Bull case

Market Leadership: Established operational scale in Aerospace & Defense.

Bear case

Macro Headwinds: Fluctuations in interest rates and sector-specific policy shifts could compress multiples.

Flip condition

Sustained quarterly EBITDA margin expansion above 20% would trigger an upgrade.

Shareholding pattern
Quarterly ownership historyLatest valid period · December 2025

Ownership distribution

Dec 2025Latest holding

Category trends

Hover over a period for exact holdings

80%53%27%0%Sept 2024Dec 2024Jun 2025Sept 2025Dec 2025
3.25%Institutional holding
25.04%Public holding
5Periods available
0.00%Promoter pledged
25.73KShareholders
Corporate Action

Complete dividend, bonus, split, rights and other action history

Record dateCorporate actionInformationAnnouncement dateEx-date
05 Aug 2026Dividend₹3.50 / share—05 Aug 2026
Delivery participation

Traded volume and delivery percentage across the latest 20 sessions

Average delivery (20D)45.51%+2.07% latest vs average
Highest delivery61.70%on 08 Oct
Average volume (20D)64.2KTrading-session average
Conviction trendStrengthening+2.07% latest reading
Traded volumeDelivery %
Peer comparison

Compare valuation, latest quarterly performance and year-on-year growth

1 companies
Company nameMarket cap ₹ CrP/E ratioDividend yield %Quarterly sales ₹ CrProfit after tax ₹ CrSales growth %Profit growth %
Sika Interplant Systems Limited
Sika Interplant Systems LimitedSIKA
Current stock
₹2,163.3462.410.34%₹42.86₹8.40-36.98%-18.84%
About Sika Interplant Systems Limited
Sika Interplant Systems Limited

Sika Interplant Systems Ltd is an engineering driven company focused on providing products, systems and services to Aerospace, Defence & Space and Automotive sectors in India.[1]

IndiaElectronic Technology

Questions investors ask
Is Sika Interplant Systems Limited Shariah compliant?

Sika Interplant Systems Limited is currently screened as Shariah Compliant under AAOIFI Shariah Standard No. 21. Business activities align with Shariah permissible sectors. Debt to Market Cap (0%) complies with AAOIFI threshold (≤ 33%).

What is Sika Interplant Systems Limited's current valuation relative to peers?

Sika Interplant Systems Limited trades at a P/E of 62.4x compared to the sector median of 62.4x, and a Price-to-Book of 13.2x.

Is the company financially healthy?

The company has a Debt-to-Equity ratio of 2.10x and a Net Debt to EBITDA ratio of 0x. Interest coverage is 45x.

What are the historical revenue and profit growth rates?

Over the past 5 years, revenue compounded at 21.4% while net profit growth averaged 24.6%.

Market data is informational and may be delayed. Shariah screening follows the displayed methodology. This is not investment advice.

Market data may be delayed. Quote date: 2026-10-09. Financial figures relate to their stated reporting periods. This information is for research and is not a recommendation to buy or sell.